4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-036248
EVP & Chief Commercial Officer sold 1,839 shares at $2.35 ($4,322)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Cheng Sohanya Roshan · EVP & Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-08 | Sale : show line 1 in the form 10b5-1 | −1,839 | $2.35 | $4,322 | 211,501 | D |
| Open-market sales · 1,839 sh · avg $2.35 · $4,322 | ||||||
Loading xslF345X04/doc4.xml…